Primary |
Product Used For Unknown Indication |
67.6% |
Suicide Attempt |
15.1% |
Drug Use For Unknown Indication |
4.9% |
Pain |
2.9% |
Back Pain |
2.6% |
Muscle Spasms |
1.9% |
Muscle Relaxant Therapy |
0.9% |
Ill-defined Disorder |
0.6% |
Neck Pain |
0.6% |
Muscle Strain |
0.5% |
Accidental Exposure |
0.3% |
Fibromyalgia |
0.3% |
Intentional Drug Misuse |
0.3% |
Nerve Compression |
0.3% |
Headache |
0.2% |
Insomnia |
0.2% |
Intervertebral Discitis |
0.2% |
Tendon Disorder |
0.2% |
Alcoholism |
0.1% |
Anxiety |
0.1% |
|
Toxicity To Various Agents |
39.3% |
Respiratory Arrest |
8.5% |
Completed Suicide |
8.1% |
Drug Toxicity |
7.6% |
Intentional Drug Misuse |
7.1% |
Cardiac Arrest |
5.2% |
Vomiting |
3.3% |
Tachycardia |
2.4% |
Cardio-respiratory Arrest |
1.9% |
Psychotic Disorder |
1.9% |
Urinary Retention |
1.9% |
Death |
1.4% |
Delirium |
1.4% |
Drug Abuse |
1.4% |
Dysuria |
1.4% |
Hypotension |
1.4% |
Neuroleptic Malignant Syndrome |
1.4% |
Rash |
1.4% |
Somnolence |
1.4% |
Torticollis |
1.4% |
|
Secondary |
Product Used For Unknown Indication |
65.0% |
Drug Use For Unknown Indication |
14.0% |
Pain |
3.9% |
Suicide Attempt |
2.7% |
Completed Suicide |
1.6% |
Back Pain |
1.3% |
Hypertension |
1.3% |
Depression |
1.2% |
Drug Exposure During Pregnancy |
1.1% |
Muscle Spasms |
1.1% |
Cardiovascular Disorder |
1.0% |
Rheumatoid Arthritis |
0.9% |
Foetal Exposure During Pregnancy |
0.8% |
Pain Management |
0.8% |
Type 2 Diabetes Mellitus |
0.8% |
Muscle Relaxant Therapy |
0.6% |
Anxiety |
0.6% |
Maternal Exposure During Pregnancy |
0.5% |
Fibromyalgia |
0.5% |
Diabetes Mellitus |
0.4% |
|
Completed Suicide |
28.4% |
Toxicity To Various Agents |
15.0% |
Respiratory Arrest |
10.4% |
Drug Abuse |
9.8% |
Death |
6.9% |
Poisoning |
6.3% |
Cardio-respiratory Arrest |
3.6% |
Intentional Drug Misuse |
3.1% |
Drug Toxicity |
2.2% |
Tachycardia |
2.2% |
Unresponsive To Stimuli |
2.1% |
Vomiting |
2.1% |
Cardiac Arrest |
1.8% |
Tremor |
1.2% |
Multiple Drug Overdose Intentional |
1.0% |
Drug Hypersensitivity |
0.9% |
Serotonin Syndrome |
0.8% |
Somnolence |
0.8% |
Viral Infection |
0.8% |
Substance Abuse |
0.6% |
|
Concomitant |
Product Used For Unknown Indication |
33.9% |
Pain |
10.5% |
Drug Use For Unknown Indication |
9.0% |
Rheumatoid Arthritis |
5.3% |
Depression |
5.0% |
Hypertension |
4.7% |
Gastrooesophageal Reflux Disease |
4.2% |
Anxiety |
3.4% |
Muscle Spasms |
3.1% |
Contraception |
2.7% |
Back Pain |
2.3% |
Fibromyalgia |
2.2% |
Insomnia |
1.8% |
Nausea |
1.8% |
Muscle Relaxant Therapy |
1.8% |
Diabetes Mellitus |
1.7% |
Blood Cholesterol Increased |
1.7% |
Multiple Sclerosis |
1.7% |
Asthma |
1.6% |
Arthritis |
1.6% |
|
Pulmonary Embolism |
10.4% |
Weight Decreased |
10.2% |
Pain |
10.1% |
Weight Increased |
8.7% |
Vomiting |
8.5% |
Urinary Tract Infection |
5.0% |
Deep Vein Thrombosis |
4.9% |
Drug Ineffective |
4.7% |
Type 2 Diabetes Mellitus |
4.3% |
Nausea |
4.2% |
Pain In Extremity |
3.8% |
Wrong Technique In Drug Usage Process |
3.4% |
Tremor |
3.2% |
White Blood Cell Count Decreased |
3.2% |
Anxiety |
3.0% |
Pneumonia |
2.6% |
Myocardial Infarction |
2.5% |
Depression |
2.5% |
Injection Site Pain |
2.5% |
Suicidal Ideation |
2.4% |
|
Interacting |
Product Used For Unknown Indication |
26.7% |
Pain |
15.6% |
Major Depression |
11.1% |
Cardiac Disorder |
6.7% |
Back Pain |
5.6% |
Anxiety |
3.3% |
Hypertension |
3.3% |
Muscle Spasms |
3.3% |
Parkinson's Disease |
3.3% |
Viral Infection |
3.3% |
Analgesic Therapy |
2.2% |
Atrial Fibrillation |
2.2% |
Back Disorder |
2.2% |
Neck Pain |
2.2% |
Nerve Block |
2.2% |
Sleep Disorder |
2.2% |
Drug Therapy Enhancement |
1.1% |
Gastrointestinal Disorder |
1.1% |
Hepatitis B |
1.1% |
Hypersensitivity |
1.1% |
|
Drug Interaction |
24.0% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
16.0% |
Serotonin Syndrome |
8.0% |
Depression |
4.0% |
Dizziness |
4.0% |
Hepatic Failure |
4.0% |
Mania |
4.0% |
Overdose |
4.0% |
Pleural Effusion |
4.0% |
Psychotic Disorder |
4.0% |
Somnambulism |
4.0% |
Spinal Disorder |
4.0% |
Viral Infection |
4.0% |
Virologic Failure |
4.0% |
Weight Decreased |
4.0% |
Weight Increased |
4.0% |
|